{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:55:22Z","timestamp":1783392922108,"version":"3.54.6"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      Imaging protocols for progressive supranuclear palsy (PSP) are increasingly incorporating different PET modalities\u2014including\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG; cerebral glucose metabolism),\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT (dopamine transporter [DAT] activity), and\n                      <jats:sup>18<\/jats:sup>\n                      F-Florzolotau (tau pathology) PET\u2014to improve diagnostic accuracy. In this cross-sectional study, we characterized tracer-specific imaging patterns and evaluated their interrelationships in patients with PSP to clarify the underlying pathophysiological mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Twenty-eight patients with clinically diagnosed PSP underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG,\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT, and\n                      <jats:sup>18<\/jats:sup>\n                      F-Florzolotau PET imaging. Quantitative voxel-based and region-of-interest analyses were conducted. Standardized uptake value ratios (SUVRs) were calculated and compared with sex-matched controls (n=20 per PET modality).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In patients with PSP compared with controls,\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET revealed significant glucose hypometabolism in frontal, parietal, cerebellar, and subcortical regions.\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET demonstrated reduced DAT availability in the striatum and midbrain. Finally,\n                      <jats:sup>18<\/jats:sup>\n                      F-Florzolotau PET showed elevated tau deposition in the thalamus, midbrain, pons, and precentral gyrus. An inverse correlation linked midbrain tau burden with local glucose metabolism (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      =\u22120.39,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.04). Frontal hypometabolism correlated strongly with subcortical metabolic deficits (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      =0.61,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Only the left putamen showed a moderate negative association between DAT loss and tau accumulation (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      =\u22120.42,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Patients with PSP exhibit metabolic deficits in cortical-subcortical networks, dopaminergic denervation in striatal-midbrain regions, and tau pathology localized to brainstem and thalamic areas. Tracer-specific SUVRs correlations revealed specific interplay among glucose hypometabolism, DAT deficiency, and tau accumulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006254","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:00:07Z","timestamp":1767207607000},"page":"220-225","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["18F-FDG, 18F-FP-CIT, and 18F-Florzolotau PET Imaging in Progressive Supranuclear Palsy"],"prefix":"10.1097","volume":"51","author":[{"given":"Menglin","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8765-0799","authenticated-orcid":false,"given":"Tianhao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Engineering Research Center of Radiographic Techniques and Equipment, Institute of High Energy Physics, Chinese Academy of Sciences"},{"name":"School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[{"name":"APRINOIA Therapeutics Co, Ltd, Suzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol"},{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","article-title":"Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome","volume":"77","author":"Jabbari","year":"2020","journal-title":"JAMA Neurol"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"fcae233","DOI":"10.1093\/braincomms\/fcae233","article-title":"Patterns of brain volume and metabolism predict clinical features in the progressive supranuclear palsy spectrum","volume":"6","author":"Ali","year":"2024","journal-title":"Brain Commun"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"e22032","DOI":"10.1002\/syn.22032","article-title":"Head-to-head comparison of (18) F-FP-CIT and (123) I-FP-CIT for dopamine transporter imaging in patients with Parkinson\u2019s disease: a preliminary study","volume":"72","author":"Lee","year":"2018","journal-title":"Synapse"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.28672","article-title":"Clinical utility of (18) F-APN-1607 tau PET imaging in patients with progressive supranuclear palsy","volume":"36","author":"Li","year":"2021","journal-title":"Mov Disord"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"R7-20260203","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00259-022-05752-6","article-title":"Unified spatial normalization method of brain PET images using adaptive probabilistic brain atlas","volume":"49","author":"Zhang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","article-title":"An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets","volume":"19","author":"Maldjian","year":"2003","journal-title":"NeuroImage"},{"key":"R9-20260203","doi-asserted-by":"crossref","first-page":"116189","DOI":"10.1016\/j.neuroimage.2019.116189","article-title":"Automated anatomical labelling atlas 3","volume":"206","author":"Rolls","year":"2020","journal-title":"NeuroImage"},{"key":"R10-20260203","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1007\/s00415-024-12350-z","article-title":"Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants","volume":"271","author":"Black","year":"2024","journal-title":"J Neurol"},{"key":"R11-20260203","doi-asserted-by":"crossref","first-page":"998255","DOI":"10.3389\/fnagi.2022.998255","article-title":"Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy","volume":"14","author":"Chen","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R12-20260203","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00259-018-4019-y","article-title":"The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage","volume":"45","author":"Yoo","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-20260203","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00259-022-06104-0","article-title":"(18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy","volume":"50","author":"Liu","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-20260203","first-page":"1754","article-title":"(18)F-PI-2620 tau PET improves the imaging diagnosis of progressive supranuclear palsy","volume":"63","author":"Messerschmidt","year":"2022","journal-title":"J Nucl Med"},{"key":"R15-20260203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R16-20260203","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"R17-20260203","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ana.23844","article-title":"Intrinsic connectivity network disruption in progressive supranuclear palsy","volume":"73","author":"Gardner","year":"2013","journal-title":"Ann Neurol"},{"key":"R18-20260203","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/awae174","article-title":"Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies","volume":"147","author":"Roemer","year":"2024","journal-title":"Brain"},{"key":"R19-20260203","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.3390\/jcm13195798","article-title":"Asymmetry in atypical parkinsonian syndromes\u2014a review","volume":"13","author":"Chunowski","year":"2024","journal-title":"J Clin Med"},{"key":"R20-20260203","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","article-title":"EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0","volume":"47","author":"Morbelli","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R21-20260203","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00259-024-06637-6","article-title":"Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies","volume":"51","author":"Ferschmann","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R22-20260203","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ana.26540","article-title":"Cell-specific dysregulation of iron and oxygen homeostasis as a novel pathophysiology in PSP","volume":"93","author":"Lee","year":"2023","journal-title":"Ann Neurol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:00:28Z","timestamp":1770141628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006254"}},"subtitle":["Region-Specific Correlations Between Glucose Metabolism, Dopaminergic Function, and Tau Pathology"],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006254","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"2025-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}